Medical Progress Report No. 3 November 2006 The Human Cost of Federal Price Negotiations: The Medicare Prescription Drug Benefit and Pharmaceutical Innovation
[table 1] [table 2] [table 3] [table 4] [table 5] [table 6] [table 7] [table 8]